White & Case and Wilson Sonsini Goodrich & Rosati advised Azurity Pharmaceuticals, Inc., and Kirkland & Ellis advised Slayback Pharma LLC on the transaction. Azurity Pharmaceuticals,...
Azurity Pharmaceuticals’ Acquisition of Slayback Pharma
GTCR’s Majority Investment in Biocoat
Kirkland & Ellis advised GTCR on the deal. GTCR announced its strategic majority investment in Biocoat, Incorporated (Biocoat), a leading medical device contract manufacturing organization. As...
MHS Global’s Combination With Fortna
Kirkland & Ellis represented MHS Global in the transaction. MHS Global, a leading global provider of material handling automation technology and systems integration, and Fortna, a...
Thoma Bravo’s Investment in Imprivata
Kirkland & Ellis advised Thoma Bravo on the deal. Latham & Watkins advised Lenders on financing the investment. Thoma Bravo, a leading software investment firm, execute...
Thoma Bravo’s Acquisition of HCSS
Kirkland & Ellis counseled Thoma Bravo on the transaction. Thoma Bravo executed the definitive agreements to acquire HCSS, a leading provider of estimating, operations and fleet management software....